Aarti Pharmalabs - News
NSE: AARTIPHARM | BSE: 543748
₹858.80
As on 04-Sep-2026 15:54IST
Market cap
₹7,798 Cr
Revenue (TTM)
₹1,969 Cr
P/E Ratio
36.6
P/B Ratio
3.6
Div. Yield
0.4 %
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsRecord Date For Dividend For FY 2025-26
17-Aug-2026No News & Announcements are available.